본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

The Potential Anti-HBV Effect of Amantadine in Combination with Ursodeoxycholic Acid and Biphenyl Dimethyl Dicarboxylate in HepG2 2.2.15 Cells

Joo Seong Soo    (Department of Immunology, College of Pharmacy, Chung-Ang University   ); Lee Do Ik    (Department of Immunology, College of Pharmacy, Chung-Ang University  );
  • 초록

    Experimental studies have demonstrated that the triple combination of amantadine (A)/ ursodeoxycholic acid (UDCA, U)/ biphenyl dimethyl dicarboxylate (DDB, D) might have a preferential antiviral effect compared with that observed in interferon-induced antiviral signal pathways, such as those of $STAT1\alpha$ and the 6-16 genes. To confirm the results, this study examined whether th signal transduction for the antiviral activity in HepG2 2.2.15 was induced dependently or independently of interferon. To accomplish this, the correlation between the $STAT1\alpha$ and 6-16 genes, and nitric oxide, for the mediation of the antiviral activity was assessed. The increase in nitric oxide in the UDCA groups suggests that the inhibition of viral gene replication was enhanced by the amantadine combinations (AU and AUD), and might be more effective if incubated for longer periods. It was found that $STAT1\alpha$ was activated by the amantadine combination, although to a lesser extent than that of $interferon-\alpha$ , and the primary endpoints examined for the inhibition of gene expression (HBsAg and HBcAg) were remarkably well regulated. This suggests that the amantadine triple, or at least the double, combination had better clinical benefits than those of $IFN-\alpha$ and the nucleoside analogue single treatment. This demonstrates that the amantadine combination might be a substitute for the existing HBV therapy if the results of in vivo and in vitro studies concur.


  • 주제어

    Hepatitis B virus .   HepG2 2.   2.   15 .   Interferon .   Amantadine .   UDCA .   DDB.  

  • 참고문헌 (28)

    1. Asmuth, D. M., Nguyen, H. H., Melcher, G. P., Cohen, S. H., and Pollar, R. B., Treatments for hepatitis B. Clin. Infect. Dis., 39, 1353-1362 (2004) 
    2. Beasley, R. P., Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer, 61, 1942-1956 (1988) 
    3. Davey, S., State of the world's vaccines and immunization. Geneva: World Health Organisation, 76-82 (1996) 
    4. Guidotti, L. G.., McClary, H., Loudis, J. M., and Chisari, F. V., Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J. Exp. Med., 191, 1247-1252 (2000) 
    5. Hancke, J. L., Burgos, R., and Ahumada F., Schisandra chinensis (Turcz) Baill. Fitotherapia, 70, 451-471 (1999) 
    6. Neuman, M. G., Blendis, L. M., Shear, N. H., Malkiewicz, I. M., Ibrahim, A., Katz, G. G., Sapir, D., Halpern, Z., Brill, S., Peretz, H., Magazinik, S. M., and Konikoff, F. M., Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy inth interferon alpha, ribavirin, and ursodeoxycholate. Clin. Biochem., 34, 183-188 (2001) 
    7. Reiss, C. S. and Komatsu, T., Does nitric oxide play a critical role in viral infection?, J. Virol., 72, 4547-4551 (1998) 
    8. Stuyver, L. J., Lostia, S., and Adams, M. et al. Antiviral activities and cellular toxicities of modified 2,3-dideoxy-2,3-Didehydrocytidine analogues. Antimicrob. Agents Chemother., 3854-3860 (2002) 
    9. Chiu, P. Y., Tang, M. H., Mak, D. H. F., Poon, M. K. T., and Ko, K. M., Hepatoprotective mechanism of schsandrin B: Role of mitochondrial glutathione antioxidant status and heat shock proteins. Free Radical Res., 35, 368-380 (2003) 
    10. Sells, M. A. and Chen, M. L., Acs, G.., Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A., 84, 1005-1009 (1987) 
    11. Locarnini, S. and Birch, C., Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIVinfected patients. J. Hepatol., 30, 536-550 (1999) 
    12. Cotonat, T., Quiroga, J. A., Lopez-Alcorocho, J. M., Clouet, R., Pardo, M., Manzarbeitia, F., and Carreno, V., Piolt study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients. Hepatology, 31, 502-506 (2000) 
    13. Platania, L. C. and Fish, E. N., Signaling pathways activated by interferons. Exp. Hematol., 27, 1583-1592 (1999) 
    14. Bonkovsky, H. L., Therapy of hepatitis C: Other options. Hepatology, 26, S143-151 (1997) 
    15. Clercq, E. D., Perspectives for the treatment of hepatitis B virus infections. Int. J. Antimicrob. Ag., 12, 81-95 (1999) 
    16. Wharton, S. A., Belshe, R. B., Skehel, J. J., and Hay, A. J., Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J. Gen. Virol., 75, 945-948 (1994) 
    17. Darnell, J. E. Jr., Kerr, I. M., and Stark, G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264, 1415-1421 (1994) 
    18. Findor, J. A., Daruich, J. Z., and Bruch, I. E., Amantadine HCl alone and associated with recombinant alpha IFN 2a during a short term therapy in chronic HCV infection. Hepatology, 26:217A (1997) 
    19. Bose, S., Kar, N., Maitra, R., Didonato, J. A., and Banerjee, A. K., Temporal activation of $NF-\kappaB$ regulates an interferonindependent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. U.S.A., 100, 10890-10895 (2003) 
    20. Lindenmann, J., From interference to interferon: a brief historical introduction. Philos. T. Roy. Soc. B., 299, 3-6 (1982) 
    21. Zhu, H., Zhao, H., Collins, C. D., Eckenrode, S. E., Run, Q., McIndoe, R. A., Crawford, J. M., Nelson, D. R., She, J. X., and Liu1, C., Gene expression association with interferon alpha antiviral activity in an HCV replicon cell line. Hepatology, 37, 1180-1188 (2003) 
    22. Fabris, P., Tositti, G.., Mazzella, G.., Zanetti, A. R., Nicolin, R., Pellizzer, G., Benedetti, P., and de Lalla, F., Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study. Aliment. Pharm. Ther., 13, 1187- 1193 (1999) 
    23. Clercq, E. D., Antivirals and antiviral strategies. Nat. Rev. Microbiol., 2, 704-720 (2004) 
    24. Huber, R., Hockenjos, B., and Blum, H. E., DDB treatment of patients with chronic hepatitis. Hepatology, 39, 1732-1733 (2004) 
    25. Abdelmalek, M. F., Harrison, M. E., Gross, Jr. J. B., Poterucha, J. J., Gossard, A. A., Spivey, J. R., Rakela, J., and Lindor, K. D., Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial. J. Clin. Gastroenterol, 26, 130-134 (1998) 
    26. Koulentaki, M., Notas, G., Petinaki, E. Valatas, V., Mouzas, I. A., Castanas, E., and Kouroumalis, E. A., Nitric oxide and proinflammatory cytokines in acute hepatitis B. Eur. J. Int. Med., 15, 35-38 (2004) 
    27. Lowenstein, C. S., Dinerman, J. L., and Snyder, S. H., Nitric oxide: a physiologic messenger. Ann. Intern. Med., 120, 227- 237 (1994) 
    28. Trauner, M. and Graziadel, I. W., Mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Aliment. Pharmacol. Ther., 13, 979-995 (1999) 
  • 이 논문을 인용한 문헌 (1)

    1. 2006. "" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, 29(5): 405~411     

 저자의 다른 논문

  • 주성수 (23)

    1. 2002 "랑게르한스세포에서 IL-1$\beta$ mRNA 발현에 대한 Pedunculagin의 효과" 약학회지 = Yakhak hoeji 46 (6): 472~476    
    2. 2002 "피부면역계 랑게르한스세포의 TNF-$\alpha$생산에 대한 Pedunculagin의 효과" 약학회지 = Yakhak hoeji 46 (6): 477~481    
    3. 2002 "Immuno Activation of Lectin-Conjugated Praecoxin A on IL-6, IL-12 Expression" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 25 (6): 954~963    
    4. 2003 "Inhibition of $IL-1{\beta}$ and IL-6 in Osteoblast-Like Cell by Isoflavones Extracted from Sophorae fructus" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 26 (12): 1029~1035    
    5. 2003 "Ursodeoxycholic Acid Inhibits Pro-Inflammatory Repertoires, $IL-1{\beta}$ and Nitric Oxide in Rat Microglia" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 26 (12): 1067~1073    
    6. 2004 "Isoflavones Extracted from Sophorae fructus Upregulate IGF-1 and TGF-$\beta$ and Inhibit Osteoclastogenesis in Rat Born Marrow Cells" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 27 (1): 99~105    
    7. 2004 "Potential Role of Ursodeoxycholic Acid in Suppression of Nuclear Factor Kappa B in Microglial Cell Line (BV-2)" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea 27 (9): 954~960    
    8. 2005 "Anti-inflammatory Effect of Bear's Gall in Rat Microglia" 동의생리병리학회지 = Journal of physiology & pathology in Korean Medicine 19 (1): 204~211    
    9. 2005 "Potential Role of Anti-inflammation by Red Ginseng in Rat Microglia" 동의생리병리학회지 = Journal of physiology & pathology in Korean Medicine 19 (1): 242~245    
    10. 2005 "난소절제 랫드에서 회화나무 이소플라본의 갱년기증상 개선효과 및 신경세포 보호효과" 약학회지 = Yakhak hoeji 49 (4): 317~322    
  • Lee, Do-Ik (46)

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기